搜索
Onconetix Inc
ONCO添加自选
0.819USD
+0.032+4.08%
收盘 07-31 16:00（美东）报价延迟15分钟
225.51K总市值
0.00市盈率 TTM
关于 Onconetix Inc 公司
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
Onconetix Inc简介
公司代码ONCO
公司名称Onconetix Inc
上市日期Feb 18, 2022
CEOFedasz (Karina M)
员工数量5
证券类型Ordinary Share
年结日Feb 18
公司地址201 E. Fifth Street
城市CINCINNATI
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编45202
电话15136204101
网址https://www.onconetix.com/
公司代码ONCO
上市日期Feb 18, 2022
CEOFedasz (Karina M)
Onconetix Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Simon Tarsh
Mr. Simon Tarsh
Independent Director
Independent Director
132.00
-6.06%
Mr. Timothy R. Ramdeen
Mr. Timothy R. Ramdeen
Independent Director
Independent Director
--
--
Dr. Thomas Meier, Ph.D.
Dr. Thomas Meier, Ph.D.
Independent Director
Independent Director
--
--
Ms. Karina M. Fedasz
Ms. Karina M. Fedasz
Interim Chief Executive Officer, Interim Chief Financial Officer
Interim Chief Executive Officer, Interim Chief Financial Officer
--
--
Mr. Andrew J. Oakley
Mr. Andrew J. Oakley
Lead Independent Director
Lead Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Simon Tarsh
Mr. Simon Tarsh
Independent Director
Independent Director
132.00
-6.06%
Mr. Timothy R. Ramdeen
Mr. Timothy R. Ramdeen
Independent Director
Independent Director
--
--
Dr. Thomas Meier, Ph.D.
Dr. Thomas Meier, Ph.D.
Independent Director
Independent Director
--
--
Ms. Karina M. Fedasz
Ms. Karina M. Fedasz
Interim Chief Executive Officer, Interim Chief Financial Officer
Interim Chief Executive Officer, Interim Chief Financial Officer
--
--
Mr. Andrew J. Oakley
Mr. Andrew J. Oakley
Lead Independent Director
Lead Independent Director
--
--
常见问题
Onconetix Inc的前五大股东是谁？
Onconetix Inc 的前五大股东如下：Mr. Simon Tarsh
有多少机构持有Onconetix Inc(ONCO)的股份？
截至2026Q1，共有29家机构持有Onconetix Inc的股份，合计持有的股份价值约为26.70K，占公司总股份的3.85%。与2025Q4相比，机构持股有所增加，增幅为2185.00。